Law360, New York (December 21, 2011, 6:53 PM ET) -- A New Jersey federal judge on Wednesday let Tris Pharma Inc. off the hook on allegations that its generic cough suppressant infringes a competitor’s patent, saying Tris had demonstrated that its product was differently formulated, but kept alive claims for an employee's trade secrets theft and unfair competition.
U.S. District Judge Freda L. Wolfson granted Tris’ motion for summary judgment of noninfringement against allegations made by Reckitt Benckiser Inc. and UCB Manufacturing Inc. that Tris’ intentions to market a generic version of Reckitt’s Delsym 7 violated...
Tris Pharma Kicks Cough Syrup Infringement Claims
To view the full article, take a free trial now.
